4164 CHENG UEI: Dividend Resolution for Key Subsidiary Xingye Biotech
NQ Score
46/100
N1 Content Completeness
10
AI Summary (NQ-processed)
CHENG UEI announced that its key subsidiary, Xingye Biotech, has resolved to distribute cash dividends.
AI Analysis
Frequently Asked Questions
- Q: What is CHENG UEI's main business?
- A: Medical equipment sales and maintenance.